A detailed history of Great West Life Assurance CO transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Great West Life Assurance CO holds 166,090 shares of DVAX stock, worth $2.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
166,090
Previous 180,359 7.91%
Holding current value
$2.11 Million
Previous $2.02 Million 8.41%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$10.05 - $11.61 $143,403 - $165,663
-14,269 Reduced 7.91%
166,090 $1.85 Million
Q2 2024

Aug 12, 2024

BUY
$10.73 - $12.58 $322,908 - $378,582
30,094 Added 20.03%
180,359 $2.02 Million
Q1 2024

May 13, 2024

BUY
$11.7 - $14.98 $69,427 - $88,891
5,934 Added 4.11%
150,265 $1.87 Million
Q4 2023

Feb 13, 2024

BUY
$13.09 - $14.98 $469,787 - $537,617
35,889 Added 33.1%
144,331 $2.01 Million
Q3 2023

Nov 14, 2023

BUY
$12.64 - $14.99 $21,867 - $25,932
1,730 Added 1.62%
108,442 $1.6 Million
Q2 2023

Aug 10, 2023

SELL
$9.85 - $13.17 $43,871 - $58,659
-4,454 Reduced 4.01%
106,712 $1.38 Million
Q1 2023

May 12, 2023

SELL
$9.44 - $11.88 $425,064 - $534,932
-45,028 Reduced 28.83%
111,166 $1.09 Million
Q4 2022

Feb 10, 2023

BUY
$10.27 - $13.29 $92,953 - $120,287
9,051 Added 6.15%
156,194 $1.66 Million
Q3 2022

Nov 01, 2022

BUY
$9.93 - $17.44 $305,655 - $536,820
30,781 Added 26.45%
147,143 $1.54 Million
Q2 2022

Aug 12, 2022

BUY
$7.45 - $12.83 $866,896 - $1.49 Million
116,362 New
116,362 $1.47 Million
Q2 2022

Aug 09, 2022

SELL
$7.45 - $12.83 $43,642 - $75,158
-5,858 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$9.16 - $19.83 $14,252 - $30,855
-1,556 Reduced 20.99%
5,858 $113,000
Q2 2021

Aug 11, 2021

BUY
$7.25 - $10.99 $23,229 - $35,211
3,204 Added 76.1%
7,414 $73,000
Q3 2020

Nov 17, 2020

SELL
$4.32 - $11.7 $50,366 - $136,410
-11,659 Reduced 73.47%
4,210 $18,000
Q3 2020

Nov 13, 2020

BUY
$4.32 - $11.7 $50,366 - $136,410
11,659 Added 276.94%
15,869 $68,000
Q4 2019

Feb 11, 2020

BUY
$3.46 - $6.93 $14,566 - $29,175
4,210 New
4,210 $24,000
Q3 2019

Oct 25, 2019

SELL
$2.69 - $4.85 $21,342 - $38,479
-7,934 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$17.3 - $24.08 $73,715 - $102,604
4,261 Added 116.01%
7,934 $148,000
Q3 2017

Nov 09, 2017

BUY
$15.2 - $21.5 $55,829 - $78,969
3,673
3,673 $78,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.61B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.